| Filter Options | ||||||
|---|---|---|---|---|---|---|
|
Public title |
Verify status |
Pay status |
||||
|
Study ailment |
Study type |
Study phase |
||||
|
Applicant |
Study leader |
Primary sponsor |
||||
|
Countries of recruitment and research settings |
|
|||||
| More Options | ||||||
| Reg No. in ChiCTR | Public title | Ailment | Type | Phase | Registration time | Viewed | Operation |
|---|---|---|---|---|---|---|---|
| NA |
Beijing Cancer Hospital |
Relapsed or refractory B-cell lymphoma |
Therapy Study |
Premarket |
2023-07-04 | 660 | Patient list |
| ChiCTR2100051525 |
Beijing Cancer Hospital; Chinese PLA General Hospital |
|
Diagnostic Accuracy Test |
|
2021-09-26 | 1128 | Patient list |
| 待审 |
Beijing Cancer Hospital |
|
Therapy Study |
Premarket |
2020-08-29 | 1196 | Patient list |
| ChiCTR2000034360 |
Study of single-agent nab-paclitaxel for the treatment of metastatic pancreatic cancer Beijing Cancer Hospital |
Metastatic pancreatic cancer |
Therapy Study |
Post-market |
2020-07-03 | 1300 | Patient list |
| ChiCTR1900026003 |
Beijing Cancer Hospital |
|
Therapy Study |
Premarket |
2019-09-17 | 1176 | Patient list |
| ChiCTR1800020142 |
Beijing Cancer Hospital |
diffuse large B-cell lymphoma |
Therapy Study |
Post-market |
2018-12-17 | 1102 | Patient list |
| ChiCTR1800018309 |
Beijing cancer hospital |
|
Therapy Study |
Post-market |
2018-09-10 | 1417 | Patient list |
| ChiCTR1800016940 |
A study on the efficacy and safety of perimentase in the treatment of adult malignant lymphoma BEIJING CANCER HOSPITAL |
|
Diagnostic Accuracy Test |
Post-market |
2018-06-29 | 833 | Patient list |
| ChiCTR1800014425 |
Beijing Cancer Hospital |
|
|
|
2018-01-12 | 1399 | Patient list |